CA2744906A1 — Progesterone-containing compositions and devices
Assigned to Individual · Expires 2009-06-04 · 17y expired
What this patent protects
The present invention is directed to progesterone-containing compositions and devices that can maintain opening of a body passageway. One aspect of the invention provides a therapeutically effective (e.g., relaxative, anti-oxidative, anti-restenotic, anti-angiogenic, and/or anti …
USPTO Abstract
The present invention is directed to progesterone-containing compositions and devices that can maintain opening of a body passageway. One aspect of the invention provides a therapeutically effective (e.g., relaxative, anti-oxidative, anti-restenotic, anti-angiogenic, and/or anti -thrombotic) composition or formulation containing progesterone and optionally vitamin E. Another aspect of the invention provides a drug eluting device with at least one coating layer comprising a progesterone composition that can minimize or eliminate inflammation, thrombosis, restenosis, neo-intimal hyperplasia, rupturing of vulnerable plaque, and/or other effects related to device implantation, treatment, or interaction. Other aspects of the invention provide for methods of using such compositions, formulations, and devices.
Drugs covered by this patent
- Estrace (ESTRADIOL) · Pfizer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.